655 
‘‘(e) COLLABORATION.—The Centers for Disease 
Control and Prevention are encouraged to collaborate with 
national, State, and local nonprofit organizations to pro-
vide information and education about asthma, and to 
strengthen such collaborations when possible. 
‘‘(f) ADDITIONAL FUNDING.—In addition to any 
other authorization of appropriations that is available to 
the Centers for Disease Control and Prevention for the 
purpose of carrying out this section, there are authorized 
to be appropriated to such Centers such sums as may be 
necessary for each of fiscal years 2017 through 2021 for 
the purpose of carrying out this section.’’. 
SEC. 778. INFLUENZA AND PNEUMONIA VACCINATION CAM-
PAIGN. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services shall— 
(1) enhance the annual campaign by the De-
partment of Health and Human Services to increase 
the number of people vaccinated each year for influ-
enza and pneumonia; and 
(2) include in such campaign the use of written 
educational materials, public service announcements, 
physician education, and any other means which the 
Secretary deems effective. 
VerDate Sep 11 2014 
08:12 Jun 15, 2016
Jkt 059200
PO 00000
Frm 00655
Fmt 6652
Sfmt 6201
E:\BILLS\H5475.IH
H5475
rmajette on DSK2TPTVN1PROD with BILLS
656 
(b) MATERIALS AND ANNOUNCEMENTS.—In carrying 
out the annual campaign described in subsection (a), the 
Secretary of Health and Human Services shall ensure 
that— 
(1) educational materials and public service an-
nouncements are readily and widely available in 
communities experiencing disparities in the incidence 
and mortality rates of influenza and pneumonia; and 
(2) the campaign uses targeted, culturally ap-
propriate messages and messengers to reach under-
served communities. 
(c) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
such sums as may be necessary for each of fiscal years 
2017 through 2021. 
SEC. 779. CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
ACTION PLAN. 
(a) FINDINGS.—The Congress finds as follows: 
(1) Chronic obstructive pulmonary disease 
(‘‘COPD’’) refers to chronic bronchitis and emphy-
sema, incurable diseases that make it difficult to ex-
hale all the air from one’s lungs, and that can cause 
persistent coughing, shortness of breath, and spu-
tum. 
VerDate Sep 11 2014 
08:12 Jun 15, 2016
Jkt 059200
PO 00000
Frm 00656
Fmt 6652
Sfmt 6201
E:\BILLS\H5475.IH
H5475
rmajette on DSK2TPTVN1PROD with BILLS
657 
(2) COPD exacerbations—episodes of acute dif-
ficulty breathing and moderate to severe fatigue— 
are dangerous, and their treatment often requires 
hospitalization. 
(3) While smoking is the primary risk factor for 
COPD, other risk factors include air pollution, occu-
pational exposures, heredity, a history of childhood 
respiratory infections, and socioeconomic status. 
(4) Over 13.5 million United States adults are 
estimated to have COPD. 
(5) COPD is the third leading cause of death 
in America, claiming over 134,000 lives in 2010. 
(6) Since 2000, deaths for women with COPD 
have exceed deaths in men. 
(7) Although African-Americans have a lower 
prevalence of COPD in the United States, research-
ers have shown that African-Americans may be 
underdiagnosed. Furthermore, research has shown 
that African-Americans develop COPD with less cu-
mulative smoke exposure and at a younger age. 
(b) IN GENERAL.—The Director of the Centers for 
Disease Control and Prevention shall conduct, support, 
and expand public health strategies, prevention, diagnosis, 
surveillance, and public and professional awareness activi-
ties regarding chronic obstructive pulmonary disease. 
VerDate Sep 11 2014 
08:12 Jun 15, 2016
Jkt 059200
PO 00000
Frm 00657
Fmt 6652
Sfmt 6201
E:\BILLS\H5475.IH
H5475
rmajette on DSK2TPTVN1PROD with BILLS
658 
(c) NATIONAL ACTION PLAN.— 
(1) DEVELOPMENT.—Not later than 2 years 
after the date of the enactment of this Act, the Di-
rector of the National Heart, Lung, and Blood Insti-
tute, in consultation with the Director of the Centers 
for Disease Control and Prevention, shall develop a 
national action plan to address chronic obstructive 
pulmonary disease in the United States with partici-
pation from patients, caregivers, health profes-
sionals, patient advocacy organizations, researchers, 
providers, public health professionals, and other 
stakeholders. 
(2) CONTENTS.—At a minimum, such plan 
shall include recommendations for— 
(A) public health interventions for the pur-
pose of implementation of the national plan; 
(B) biomedical, health services, and public 
health research on chronic obstructive pul-
monary disease; and 
(C) inclusion of chronic obstructive pul-
monary disease in the health data collections of 
all Federal agencies. 
(3) CONSIDERATION.—In developing such plan, 
the Director of the National Heart, Lung, and Blood 
Institute shall consider the recommendations and 
VerDate Sep 11 2014 
08:12 Jun 15, 2016
Jkt 059200
PO 00000
Frm 00658
Fmt 6652
Sfmt 6201
E:\BILLS\H5475.IH
H5475
rmajette on DSK2TPTVN1PROD with BILLS
659 
findings of the Institute of Medicine in the report 
entitled ‘‘A Nationwide Framework for Surveillance 
of Cardiovascular and Chronic Lung Diseases’’ (July 
22, 2011). 
(d) CHRONIC DISEASE PREVENTION PROGRAMS.— 
The Director of the National Heart, Lung, and Blood In-
stitute shall carry out the following: 
(1) Conduct public education and awareness ac-
tivities with patient and professional organizations 
to stimulate earlier diagnosis and improve patient 
outcomes from treatment of chronic obstructive pul-
monary disease. To the extent known and relevant, 
such public education and awareness activities shall 
reflect differences in chronic obstructive pulmonary 
disease by cause (tobacco, environmental, occupa-
tional, biological, and genetic) and include a focus 
on outreach to undiagnosed and, as appropriate, mi-
nority populations. 
(2) Supplement and expand upon the activities 
of the National Heart, Lung, and Blood Institute by 
making grants to nonprofit organizations, State and 
local jurisdictions, and Indian tribes for the purpose 
of reducing the burden of chronic obstructive pul-
monary disease, especially in disproportionately im-
VerDate Sep 11 2014 
08:12 Jun 15, 2016
Jkt 059200
PO 00000
Frm 00659
Fmt 6652
Sfmt 6201
E:\BILLS\H5475.IH
H5475
rmajette on DSK2TPTVN1PROD with BILLS